Quest Diagnostics Incorporated
Quest Diagnostics Incorporated（DGX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · DGX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
35
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Quest Diagnostics Incorporated内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
DGX 季度内部人买卖趋势
DGX 内幕交易卖出 · DGX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · DGX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
DGX 高管卖出股份 · DGX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Davis J. E. CEO and President · Director | Sale | 10,000 | $1.94M⚡ | Form 4 |
| May 20, 2026 | CARTER ROBERT B Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | Gregg Vicky B Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | Diaz Luis Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | MAIN TIMOTHY L Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | WENTWORTH TIMOTHY C Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | Doi Tracey Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | RING TIMOTHY M Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | Lassiter Wright III Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | MORRISON DENISE M Director | Award | 1,142 | — | Form 4 |
| May 20, 2026 | PFEIFFER GARY M Director | Award | 1,142 | — | Form 4 |
| Apr 20, 2026 | SAMAD SAM Executive Vice President & CFO | Award | 108 | $21K | Form 4 |
| Apr 20, 2026 | Plewman Patrick SVP for Diagnostic Services | Other | 49 | $10K | Form 4 |
| Apr 20, 2026 | Gregg Vicky B Director | Award | 68 | $13K | Form 4 |
| Apr 20, 2026 | CARTER ROBERT B Director | Other | 7 | $1K | Form 4 |
| Apr 20, 2026 | Lassiter Wright III Director | Other | 6 | $1K | Form 4 |
| Apr 20, 2026 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Other | 39 | $8K | Form 4 |
| Apr 20, 2026 | DELANEY MARK E SVP & Chief Commercial Officer | Other | 37 | $7K | Form 4 |
| Mar 9, 2026 | WENTWORTH TIMOTHY C Director | Award | 215 | — | Form 4 |
| Mar 4, 2026 | SAMAD SAM Executive Vice President & CFO | Award | 13,947 | $2.86M⚡ | Form 4 |
| Mar 4, 2026 | SAMAD SAM Executive Vice President & CFO | Other | 7,720 | $1.58M⚡ | Form 4 |
| Mar 4, 2026 | Doherty Catherine T. EVP, Regional Businesses | Award | 11,364 | $2.33M⚡ | Form 4 |
| Mar 4, 2026 | Doherty Catherine T. EVP, Regional Businesses | Other | 5,806 | $1.19M⚡ | Form 4 |
| Mar 5, 2026 | Doherty Catherine T. EVP, Regional Businesses | Sale | 5,558 | $1.15M⚡ | Form 4 |
| Mar 4, 2026 | DELANEY MARK E SVP & Chief Commercial Officer | Award | 5,682 | $1.16M⚡ | Form 4 |
Davis J. E.
CEO and President · Director
日期
Jun 1
股数
10,000
均价
$194.14
总金额
$1.94M ⚡
SAMAD SAM
Executive Vice President & CFO
日期
Mar 4
股数
13,947
均价
$204.86
总金额
$2.86M ⚡
SAMAD SAM
Executive Vice President & CFO
日期
Mar 4
股数
7,720
均价
$204.86
总金额
$1.58M ⚡
Doherty Catherine T.
EVP, Regional Businesses
日期
Mar 4
股数
11,364
均价
$204.86
总金额
$2.33M ⚡
Doherty Catherine T.
EVP, Regional Businesses
日期
Mar 4
股数
5,806
均价
$204.86
总金额
$1.19M ⚡
Doherty Catherine T.
EVP, Regional Businesses
日期
Mar 5
股数
5,558
均价
$206.21
总金额
$1.15M ⚡
DELANEY MARK E
SVP & Chief Commercial Officer
日期
Mar 4
股数
5,682
均价
$204.86
总金额
$1.16M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 DGX 内幕交易
DGX 内幕交易
Quest Diagnostics Incorporated（DGX）内幕交易数据来源于公司内部人（包括Doherty Catherine T. (EVP, Regional Businesses), Plewman Patrick (SVP for Diagnostic Services), PREVOZNIK MICHAEL E (SVP & General Counsel)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。DGX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Quest Diagnostics Incorporated机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
DGX 内幕交易 · 5个问题Quest Diagnostics Incorporated（DGX）的内部人包括高管和董事，如Doherty Catherine T. (EVP, Regional Businesses), Plewman Patrick (SVP for Diagnostic Services), PREVOZNIK MICHAEL E (SVP & General Counsel)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026